Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12719 | TPP | 2/2 | 3 years, 4 months ago 26 October 2022 21:55:03 UTC | View, Job request 12719 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12708 | TPP | 2/2 | 3 years, 4 months ago 26 October 2022 15:23:22 UTC | View, Job request 12708 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12694 | TPP | 1/2 | 3 years, 4 months ago 26 October 2022 10:41:04 UTC | View, Job request 12694 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12692 | TPP | 0/1 | 3 years, 4 months ago 26 October 2022 10:05:09 UTC | View, Job request 12692 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12691 | TPP | 1/1 | 3 years, 4 months ago 26 October 2022 09:59:54 UTC | View, Job request 12691 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12685 | TPP | 0/1 | 3 years, 4 months ago 25 October 2022 22:12:15 UTC | View, Job request 12685 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12683 | TPP | 1/1 | 3 years, 4 months ago 25 October 2022 21:55:05 UTC | View, Job request 12683 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12682 | TPP | 0/1 | 3 years, 4 months ago 25 October 2022 21:47:13 UTC | View, Job request 12682 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12681 | TPP | 0/1 | 3 years, 4 months ago 25 October 2022 21:31:18 UTC | View, Job request 12681 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12680 | TPP | 0/1 | 3 years, 4 months ago 25 October 2022 21:17:19 UTC | View, Job request 12680 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12678 | TPP | 1/1 | 3 years, 4 months ago 25 October 2022 20:57:29 UTC | View, Job request 12678 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12677 | TPP | 1/2 | 3 years, 4 months ago 25 October 2022 18:12:01 UTC | View, Job request 12677 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12673 | TPP | 2/2 | 3 years, 4 months ago 25 October 2022 17:17:50 UTC | View, Job request 12673 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12672 | TPP | 0/2 | 3 years, 4 months ago 25 October 2022 16:57:47 UTC | View, Job request 12672 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12671 | TPP | 1/1 | 3 years, 4 months ago 25 October 2022 15:41:03 UTC | View, Job request 12671 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12668 | TPP | 1/1 | 3 years, 4 months ago 25 October 2022 15:22:01 UTC | View, Job request 12668 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12666 | TPP | 0/1 | 3 years, 4 months ago 25 October 2022 15:05:09 UTC | View, Job request 12666 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12648 | TPP | 1/1 | 3 years, 4 months ago 24 October 2022 21:36:55 UTC | View, Job request 12648 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12618 | TPP | 1/1 | 3 years, 4 months ago 23 October 2022 11:22:06 UTC | View, Job request 12618 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12617 | TPP | 1/1 | 3 years, 4 months ago 23 October 2022 10:47:13 UTC | View, Job request 12617 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12611 | TPP | 0/1 | 3 years, 4 months ago 22 October 2022 15:55:06 UTC | View, Job request 12611 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12610 | TPP | 0/1 | 3 years, 4 months ago 22 October 2022 15:48:51 UTC | View, Job request 12610 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12609 | TPP | 1/1 | 3 years, 4 months ago 22 October 2022 15:32:53 UTC | View, Job request 12609 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12593 | TPP | 1/1 | 3 years, 4 months ago 21 October 2022 21:34:00 UTC | View, Job request 12593 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12587 | TPP | 1/1 | 3 years, 4 months ago 20 October 2022 14:44:13 UTC | View, Job request 12587 |